Regional and rural Australians battling advanced or incurable cancers will soon have free access to Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) – a program for genomic profiling.
The pioneering initiative will allow experts to match cancer patients with precise treatments, including clinical trials.
Head of Support and Operations at Rare Cancers Australia Christie Cockburn says the initiative delivers new hope for those diagnosed with some of the toughest cancers to treat.
Article continues after this ad
Advertisement
